subscribeSubscribe
price-trendAsk Us
EyePoint Pharma Secures New Purchase and Marketing Agreement with Vantage

EyePoint Pharma Secures New Purchase and Marketing Agreement with Vantage
GLOBENEWSWIRE
24 Aug 2020
Share Share
Ocular Announces Its First Published Physician Fee Schedule for Administration

Ocular Announces Its First Published Physician Fee Schedule for Administration
BUSINESSWIRE
14 Jul 2020
Share Share
FDA Action Alert: Karyopharm, Merck and Celgene

FDA Action Alert: Karyopharm, Merck and Celgene
Mark Terry BIOSPACE
01 Jul 2019
Share Share
Tedor Pharma Withdrawal of Approval of 10 Abbreviated New Drug Applications

Tedor Pharma Withdrawal of Approval of 10 Abbreviated New Drug Applications
FDA
08 Nov 2018
Share Share
Top 10: Takeda’s late-stage pipeline will rely heavily on Shire drugs

Top 10: Takeda’s late-stage pipeline will rely heavily on Shire drugs
By Meiling ENDPTS
31 Jul 2018
Share Share
First treatment recommended for rare bone disease

First treatment recommended for rare bone disease
EMA
26 Jun 2015
Share Share
Anvisa suspends Dexadoze manufactured by Laboratorio Teuto Brasileiro S / A

Anvisa suspends Dexadoze manufactured by Laboratorio Teuto Brasileiro S / A
ANVISA
11 Jun 2015
Share Share